These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 9875231

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. IgE binding properties of the recombinant ovomucoid third domain expressed in Escherichia coli.
    Sasaki E, Mine Y.
    Biochem Biophys Res Commun; 2001 Apr 13; 282(4):947-51. PubMed ID: 11352643
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Allergenic properties of ovomucoid in man.
    Cooke SK, Sampson HA.
    J Immunol; 1997 Aug 15; 159(4):2026-32. PubMed ID: 9257870
    [Abstract] [Full Text] [Related]

  • 5. Identification and fine mapping of IgG and IgE epitopes in ovomucoid.
    Mine Y, Wei Zhang J.
    Biochem Biophys Res Commun; 2002 Apr 12; 292(4):1070-4. PubMed ID: 11944924
    [Abstract] [Full Text] [Related]

  • 6. Specific T cell lines for ovalbumin, ovomucoid, lysozyme and two OA synthetic epitopes, generated from egg allergic patients' PBMC.
    Holen E, Elsayed S.
    Clin Exp Allergy; 1996 Sep 12; 26(9):1080-8. PubMed ID: 8889264
    [Abstract] [Full Text] [Related]

  • 7. Specificity of IgE antibodies to sequential epitopes of hen's egg ovomucoid as a marker for persistence of egg allergy.
    Järvinen KM, Beyer K, Vila L, Bardina L, Mishoe M, Sampson HA.
    Allergy; 2007 Jul 12; 62(7):758-65. PubMed ID: 17573723
    [Abstract] [Full Text] [Related]

  • 8. Characterization of residues in human IgE and IgG binding site by chemical modification of ovomucoid third domain.
    Zhang JW, Mine Y.
    Biochem Biophys Res Commun; 1999 Aug 11; 261(3):610-3. PubMed ID: 10441474
    [Abstract] [Full Text] [Related]

  • 9. [Antigenic determinants on ovalbumin and ovomucoid: comparison of the specificity of IgG and IgE antibodies].
    Honma K, Aoyagi M, Saito K, Nishimuta T, Sugimoto K, Tsunoo H, Niimi H, Kohno Y.
    Arerugi; 1991 Sep 11; 40(9):1167-75. PubMed ID: 1720303
    [Abstract] [Full Text] [Related]

  • 10. Mapping of the IgE and IgG4 sequential epitopes of ovomucoid with a peptide microarray immunoassay.
    Martínez-Botas J, Cerecedo I, Zamora J, Vlaicu C, Dieguez MC, Gómez-Coronado D, de Dios V, Terrados S, de la Hoz B.
    Int Arch Allergy Immunol; 2013 Sep 11; 161(1):11-20. PubMed ID: 23257567
    [Abstract] [Full Text] [Related]

  • 11. A novel approach for investigation of specific and cross-reactive IgE epitopes on Bet v 1 and homologous food allergens in individual patients.
    Mittag D, Batori V, Neudecker P, Wiche R, Friis EP, Ballmer-Weber BK, Vieths S, Roggen EL.
    Mol Immunol; 2006 Feb 11; 43(3):268-78. PubMed ID: 16199263
    [Abstract] [Full Text] [Related]

  • 12. Genetically glycosylated ovomucoid third domain can modulate Immunoglobulin E antibody production and cytokine response in BALB/c mice.
    Rupa P, Nakamura S, Mine Y.
    Clin Exp Allergy; 2007 Jun 11; 37(6):918-28. PubMed ID: 17517106
    [Abstract] [Full Text] [Related]

  • 13. Human immunoglobulin E (IgE) binding to heated and glycated ovalbumin and ovomucoid before and after in vitro digestion.
    Jiménez-Saiz R, Belloque J, Molina E, López-Fandiño R.
    J Agric Food Chem; 2011 Sep 28; 59(18):10044-51. PubMed ID: 21846147
    [Abstract] [Full Text] [Related]

  • 14. Utility of ovomucoid-specific IgE concentrations in predicting symptomatic egg allergy.
    Ando H, Movérare R, Kondo Y, Tsuge I, Tanaka A, Borres MP, Urisu A.
    J Allergy Clin Immunol; 2008 Sep 28; 122(3):583-8. PubMed ID: 18692888
    [Abstract] [Full Text] [Related]

  • 15. Human IgE antibody to the carbohydrate-containing third domain of chicken ovomucoid.
    Matsuda T, Nakamura R, Nakashima I, Hasegawa Y, Shimokata K.
    Biochem Biophys Res Commun; 1985 Jun 14; 129(2):505-10. PubMed ID: 2409965
    [Abstract] [Full Text] [Related]

  • 16. Kinetic analysis of pepsin digestion of chicken egg white ovomucoid and allergenic potential of pepsin fragments.
    Takagi K, Teshima R, Okunuki H, Itoh S, Kawasaki N, Kawanishi T, Hayakawa T, Kohno Y, Urisu A, Sawada J.
    Int Arch Allergy Immunol; 2005 Jan 14; 136(1):23-32. PubMed ID: 15591810
    [Abstract] [Full Text] [Related]

  • 17. Genetic attachment of undecane peptides to ovomucoid third domain can suppress the production of specific IgG and IgE antibodies.
    Mine Y, Rupa P.
    Biochem Biophys Res Commun; 2003 Nov 07; 311(1):223-8. PubMed ID: 14575717
    [Abstract] [Full Text] [Related]

  • 18. Reduction of antigenicity and allergenicity of genetically modified egg white allergen, ovomucoid third domain.
    Mine Y, Sasaki E, Zhang JW.
    Biochem Biophys Res Commun; 2003 Feb 28; 302(1):133-7. PubMed ID: 12593859
    [Abstract] [Full Text] [Related]

  • 19. Engineered recombinant ovomucoid third domain can desensitize Balb/c mice of egg allergy.
    Rupa P, Mine Y.
    Allergy; 2006 Jul 28; 61(7):836-42. PubMed ID: 16792581
    [Abstract] [Full Text] [Related]

  • 20. Specificities of IgE, IgG and IgA antibodies to ovalbumin. Comparison of binding activities to denatured ovalbumin or ovalbumin fragments of IgE antibodies with those of IgG or IgA antibodies.
    Honma K, Kohno Y, Saito K, Shimojo N, Tsunoo H, Niimi H.
    Int Arch Allergy Immunol; 1994 Jul 28; 103(1):28-35. PubMed ID: 7505140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.